ダイアストリック心不全:ダイアストリック機能不全に関連した心筋コラーゲン周回量の増加の証拠
Ramón Martos1, John Baugh, Mark Ledwidge
1Heart Failure Unit, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Circulation
|February 7, 2007
まとめ
ダイアストリック心不全 (DHF) は,活発な線維症を伴い,心室の硬さを増加させます. この研究では,高血圧患者で高血圧FHのコラーゲンとマトリックスメタルプロテインアースマーカーの上昇が認められ,この状態に寄与する線維性プロセスを示唆した.
科学分野:
- 心臓病学 心臓病学
- バイオケミストリー バイオケミストリー
- 病理生理学 病理生理学とは
背景:
- ダイアストリック心不全 (DHF) の病理生理学は不明であり,潜在的に活性線維症と心室の硬直性の増加を伴う可能性があります.
- 高血圧は重要な危険因子であり,腹動脈機能と心臓の充満に影響を及ぼします.
研究 の 目的:
- 高血圧患者のコラーゲン代謝を,異なるダイアストリック機能段階において調査する.
- DHFとそれ以外の患者における線維性マーカーの役割を決定する.
主な方法:
- DHFの存在とダイアストリック機能の重度によって分類された86人の高血圧患者を研究した.
- プロコラーゲンペプチド (タイプI,III),マトリックス金属タンパク質酵素 (MMPs),およびMMPsの組織阻害剤の血清濃度の測定.
- ディアストリック充填パラメータ (E/A比率,減速時間,イソボリュームリラクゼーション時間) を評価するためにドップラーエコーカルディオグラフィーを利用しました.
主要な成果:
- DHFの患者は,DHFのない患者と比較して,血清のプロコラーゲンI型カルボキシ末端テロペプチド,プロコラーゲンIII型アミノ末端プロペプチド,MMP-2およびMMP-9のレベルが著しく高かった.
- より重度のダイアストリック機能障害の段階は,コラーゲンペプチド,MMP-2,およびMMP-1の組織阻害剤のレベルの増加と相関していました.
- ディアストリック機能不全の各段階において,DHF患者は一貫して線維性マーカーの上昇を示した.
結論:
- 血清学的証拠は,DHFにおける活発な線維性プロセスを支持する.
- 線維性マーカーは,下痢機能障害の進行段階でより顕著です.
- 発見は,DHFの病理生理学を明らかにし,新しい診断および治療目標を示唆する可能性があります.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Cardiomyopathy IV: Restrictive Cardiomyopathy
648
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
648
Cardiomyopathy II: Dilated Cardiomyopathy
649
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K


